Peter Lamb, a partner in our Silicon Valley office, is a member of the Corporate and Capital Markets Groups. Pete advises both emerging and well-established private and public technology and life sciences companies, as well as private equity sponsors.

He has advised on the IPOs of companies such as Elevate Financial, AVG Technologies, Pandora Media, Chegg, Portola Pharmaceuticals, Versartis and ZS Pharma.  He also recently advised IronPlanet on its dual track IPO/M&A process that resulted in its sale to Ritchie Brothers.  His experience includes a wide range of public and private company M&A, growth equity and public market financings for tech, life sciences and private equity clients, including numerous cross-border buy- and sell-side M&A presentations, including the recent US$1.4 billion sale of AVG Technologies to Avast Software.

Peter also advises private equity funds like Warburg Pincus, Vista Equity Partners and their portfolio companies on M&A and minority and majority investments, particularly in enterprise software companies, as well as a range of late-stage private technology companies, including Pinterest, Planet Labs, Stripe and Twist Bioscience and Zimperium on general corporate, M&A and financing matters. Prior to joining Orrick, Pete was with Davis Polk & Wardwell.


  • Representative Clients   

    • Aptean    
    • Elasticsearch Global BV
    • Janrain
    • Ladder Life   
    • Pinterest
    • Stripe
    • Twist Bioscience
    • Warburg Pincus

    Selected General Corporate Advisory

    • Securities law compliance, corporate governance and reporting advice for companies like AVG Technologies, Elastic, Ladder Life, Pinterest, Stripe, Twist.

    Selected Mergers & Acquisitions

    • AVG in its $1.3 billion acquisition by Avast.
    • Micrel in its $840 million sale to Microchip.
    • Palm in its $1.2 billion sale to HP.    
    • Ingram Micro in its $840 million acquisition of BrightPoint.
    • Various add on acquisitions for Vista Equity Partners’ portfolio company Aptean.
    • Shire’s asset sale of its Dermagraft business to Organogenesis.       
    • Vector Capital in its acquisition of Symantec’s application management business.    

    Selected Pro Bono

    • Board Member, Youth Rights & Justice.
    • Various pro bono representations, including National Center for Youth Law and Microcredit Enterprises, a non-profit microfinance organization, in the negotiation of its credit agreement with the Overseas Private Investment Corporation (OPIC)

Insights

News